The quantification of circular RNA 0007841 during induction therapy helps estimate the response and survival benefits to bortezomib-based regimen in multiple myeloma
ConclusionCirc_0007841 quantification during induction therapy may reflect the response and survival benefits to bortezomib-based regimen in MM patients.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | General Medicine | Ireland Health | Myeloma | Science | Study | Velcade